COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Schizophrenia is a complex psychiatric disorder with a significant genetic component.
• Catechol-O-methyl transferase (COMT) and brain-derived neurotrophic factor (BDNF) are implicated in brain function and may play a role in schizophrenia.
• Specific gene polymorphisms, such as COMT Val(158)Met and BDNF C(270)T, are investigated for their potential contribution to disease liability.

Purpose of the Study:

• To investigate the association between catechol-O-methyl transferase (COMT) Val(158)Met and brain-derived neurotrophic factor (BDNF) C(270)T gene polymorphisms and schizophrenia.
• To determine if these genetic variations influence susceptibility to schizophrenia in individuals of European ancestry.

Main Methods:

• A multicenter study was conducted with 217 subjects of European ancestry.
• The study included 106 patients diagnosed with schizophrenia and 111 healthy control subjects.
• Genotyping for COMT Val(158)Met and BDNF C(270)T polymorphisms was performed and analyzed.

Main Results:

• No significant differences were observed in the genotype distribution of COMT Val(158)Met between schizophrenia patients and healthy controls.
• Similarly, the allele distribution for the BDNF C(270)T polymorphism did not differ between the patient and control groups.
• These findings indicate no statistical association between the examined COMT and BDNF gene polymorphisms and schizophrenia in this cohort.

Conclusions:

• The results do not support the hypothesis that the COMT Val(158)Met or BDNF C(270)T gene polymorphisms are associated with the liability to schizophrenia.
• Further research may be needed to explore other genetic factors or environmental influences contributing to schizophrenia.